Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
July 5, 2021 4:43 am | Leave your thoughts
Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Division of Research, Kaiser Permanente Northern California, Oakland, Ca. Background: This study aims to explain relationships of maternal psychiatric conditions and selective serotonin reuptake inhibitor (SSRI) use during preconception and maternity with threat of neurodevelopmental disorders in offspring. Practices: We utilized data through...